Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2010
06/10/2010US20100146664 Resistance to Abiotic Stress in Plants
06/10/2010US20100146663 Nucleotide Sequences and Polypeptides Encoded Thereby Useful for Modifying plant Characteristics
06/10/2010US20100146661 Sugar beet genes involved in stress tolerance
06/10/2010US20100146659 Plant Virus Designated Tomato Marchitez Virus
06/10/2010US20100146656 Parthenocarpic Genetic Elements Derived From S. Habrochaites
06/10/2010US20100146655 Methods and materials for producing transgenic animals
06/10/2010US20100146654 Unactivated oocytes as cytoplast recipients for nuclear transfer
06/10/2010US20100146653 Macrophage cell-lines for propagation of porcine reproductive and respiratory syndrome virus
06/10/2010US20100146652 Xenobiotic related induction of gene expression
06/10/2010US20100146651 Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
06/10/2010US20100146650 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
06/10/2010US20100146649 Purkinje Cell-Tropic Viral Vector
06/10/2010US20100146648 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
06/10/2010US20100146644 Transgenic non-human animal
06/10/2010US20100145889 Recombinant constructs and transgenic fluorescent ornamental fish therefrom
06/10/2010US20100145037 Dna amplification and sequencing using dna molecules generated by random fragmentation
06/10/2010US20100145030 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
06/10/2010US20100145024 Long wavelength engineered fluorescent proteins
06/10/2010US20100145023 Optimized Nucleotide Sequences of VB6-845 For Expression of Recombinant Proteins
06/10/2010US20100145016 Compositions and methods for purifying calreticulin
06/10/2010US20100145015 Compositions and methods for increasing immunogenicity of glycoprotein vaccines
06/10/2010US20100144893 Isoprenoid synthases
06/10/2010US20100144849 METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF
06/10/2010US20100144847 Fusion polypeptide suitable as a cytotoxin
06/10/2010US20100144846 Oligoribonucleotides and uses thereof
06/10/2010US20100144844 RNAi-MEDIATED INHIBITION OF H1F1A FOR TREATMENT OF OCULAR ANGIOGENESIS
06/10/2010US20100144843 Rnai therapeutic for respiratory virus infection
06/10/2010US20100144841 Control of nk cell function and survival by modulation of ship activity
06/10/2010US20100144837 Diagnosis and treatment of malignant neoplasms
06/10/2010US20100144835 Inhibition of gpr4
06/10/2010US20100144834 Methods for treating hypercholesterolemia
06/10/2010US20100144831 Blocking of gene expression in eukaryotic cells
06/10/2010US20100144677 Method for screening agents for the treatment of diabetes
06/10/2010US20100144641 Compositions Having Antiangiogenic Activity and Uses Thereof
06/10/2010US20100144640 Molecules designated b7l-1
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/10/2010US20100144633 Chloroplast expression of membrane proteins
06/10/2010US20100144632 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity
06/10/2010US20100144601 Anti-TNF Alpha Fibronectin Type III Domain Based Scaffold Compositions, Methods and Uses
06/10/2010US20100144575 Alpha-Amylase Mutants
06/10/2010US20100144555 Qualitative differential screening
06/10/2010US20100144552 siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)
06/10/2010US20100144551 Cytokine production regulator gene and use thereof
06/10/2010US20100144549 Parthenote-derived stem cells and methods of making and using them
06/10/2010US20100144548 Vector systems
06/10/2010US20100144546 Genetic selection for protein folding and solubility in the bacterial periplasm
06/10/2010US20100144530 Identification of a new class of epsp synthases
06/10/2010US20100144529 Identification of a new class of epsp synthases
06/10/2010US20100144041 for the production of ethanol by introducing and expressing bacterial araA, araB and araD genes; polynucleotide encoding an isolated non-conventional yeast arabinose transporter; biofuels
06/10/2010US20100144040 Cells and methodology to generate non-segmented negative-strand rna viruses
06/10/2010US20100144039 Pluripotency determining factors and uses thereof
06/10/2010US20100144038 Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell
06/10/2010US20100144031 Methods for reprogramming somatic cells
06/10/2010US20100144029 Facilitating Protein Solubility by Use of Peptide Extensions
06/10/2010US20100144028 Method And Device For Continuous Membrane Adsorption
06/10/2010US20100144027 Placental protein having a regulating action on proteolytic activity and its related gene
06/10/2010US20100144026 siRNA-mediated gene silencing with viral vectors
06/10/2010US20100144025 Hla-binding peptide, precursor thereof, dna fragment and recombinant vector encoding the same
06/10/2010US20100144012 A single chain homing endonuclease, comprising a first variant of I-CreI having the amino acid sequence of accession number pdb 1g9y; for genome engineering and gene therapy
06/10/2010US20100144010 Enzymatic Asymmetric Decarboxylation of Disubstituted Malonic Acids
06/10/2010US20100143989 Production Of 3-Hydroxycarboxylic Acid Using Nitrilase Mutants
06/10/2010US20100143981 Whole-cell catalytic system comprising a hydantoinase, a racemase and a carbamoylase
06/10/2010US20100143979 Polypeptides having dna polymerase activity
06/10/2010US20100143973 Interleukin-11 Fusion Proteins
06/10/2010US20100143971 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
06/10/2010US20100143970 Transglutaminase having disulfide bond introduced therein
06/10/2010US20100143968 Penicillin-g acylases
06/10/2010US20100143946 Alpha-synuclein kinase
06/10/2010US20100143940 (3r)-hydroxyacyl-acp dehydratase enzymes used in the biosynthesis of mycolic acids and use of same for screening antibiotics
06/10/2010US20100143939 Intracellular antibodies
06/10/2010US20100143918 Translocation and mutant ros kinase in human non-small cell lung carcinoma
06/10/2010US20100143916 Osteoarthritis biomarkers and uses thereof
06/10/2010US20100143911 Method for screening essential metabolites in growth of microorganisms
06/10/2010US20100143896 Sequence capable of enhancing the expression of gene under moderately low temperature
06/10/2010US20100143892 Use of ribozymes in the detection of adventitious agents
06/10/2010US20100143536 Compositions and methods for reducing h2s levels in fermented beverages
06/10/2010US20100143532 Animal feed with low phytic acid, oil burdened and protein laden grain
06/10/2010US20100143458 Glutamic acid decarboxylase (gad) based delivery system
06/10/2010US20100143457 Extended soluble PH20 polypeptides and uses thereof
06/10/2010US20100143450 DEVELOPMENT OF ASTHMA THERAPY WITH rAAV-mediated AMCase shRNA
06/10/2010US20100143442 Growth factor complexes and modulation of cell migration and growth
06/10/2010US20100143415 Streptococcus Pneumoniae Antigens
06/10/2010US20100143412 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
06/10/2010US20100143410 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
06/10/2010US20100143408 Papillomavirus vaccines
06/10/2010US20100143407 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
06/10/2010US20100143402 Intergenic sites between conserved genes in the genome of modified vaccinia ankara (mva) vaccinia virus
06/10/2010US20100143395 Material with immunogenicity
06/10/2010US20100143390 Polypeptides for inducing a protective immune response against staphylococcus epidermidis
06/10/2010US20100143386 FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs
06/10/2010US20100143376 Antibodies Specific for Rubella Virus
06/10/2010US20100143367 Novel anti-cd98 antibody
06/10/2010US20100143363 Cd161 ligand, pilar, for modulating activation and proliferation of t cells
06/10/2010US20100143362 LINGO binding molecules and Pharmaceutical Use Thereof
06/10/2010US20100143360 Human vascular endothelial growth factor 2
06/10/2010US20100143359 Expression of foxp3 by cancer cells
06/10/2010US20100143342 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies
06/10/2010US20100143323 Modified phosphatases
06/10/2010US20100143315 Method for Improving the Specific Effector Function of Single-Chain Antigen-Recognizing Genetic Constructs (SCARC) Through Murinization Thereof
06/10/2010US20100143314 In Vivo Production and Delivery of Erythropoietin or Insulinotropin for Gene Therapy
1 ... 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 ... 4023